Additive anti-hyperalgesia of electroacupuncture and intrathecal antisense oligodeoxynucleotide to interleukin-1 receptor type I on carrageenan-induced inflammatory pain in rats

Brain Research Bulletin

Volumn 78, Issue 6, 2009, Pages 335-341

  Song, Ming Juan ^a   Wang, Yan Qing ^a   Wu, Gen Cheng ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Carrageenan; Electroacupuncture; Inflammatory pain; Interleukin 1 receptor type I; Interleukin 1 ; Spinal cord

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; CARRAGEENAN; INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 1BETA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ELECTROACUPUNCTURE; HYPERALGESIA; INFLAMMATION; MALE; NONHUMAN; PAIN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SPINAL CORD;

ANIMALS; CARRAGEENAN; DOWN-REGULATION; ELECTROACUPUNCTURE; HOT TEMPERATURE; HYPERALGESIA; INJECTIONS, SPINAL; INTERLEUKIN-1BETA; LIGHT; MALE; OLIGONUCLEOTIDES, ANTISENSE; PAIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, INTERLEUKIN-1 TYPE I; RNA, MESSENGER; SPINAL CORD;

EID: 58949105084     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainresbull.2008.10.009     Document Type: Article

References (41)

1. Abdul M., and Hoosein N. Relationship of the interleukin-1 system with neuroendocrine and exocrine markers in human colon cancer cell lines. Cytokine 18 (2002) 86-91
2. Akhtar S., and Agrawal S. In vivo studies with antisense oligonucleotides. Trends Pharmacol. Sci. 18 (1997) 12-18
3. Arend W.P. Interleukin-1 receptor antagonist. Adv. Immunol. 54 (1993) 167-227
4. Bourke E., Cassetti A., Villa A., Fadlon E., Colotta F., and Mantovani A. IL-1 beta scavenging by the type II IL-1 decoy receptor in human neutrophils. J. Immunol. 170 (2003) 5999-6005
5. Burch R.M., and Mahan L.C. Oligonucleotides antisense to the interleukin 1 receptor mRNA block the effects of interleukin 1 in cultured murine and human fibroblasts and in mice. J. Clin. Invest. 88 (1991) 1190-1196
6. Chae Y., Hong M.S., Kim G.H., Hahm D.H., Park H.J., Ha E., Kim M.J., Park H.J., Yang J., and Lee H. Protein array analysis of cytokine levels on the action of acupuncture in carrageenan-induced inflammation. Neurol. Res. 29 (2007) S55-58
7. Cheng X. Chinese Acupuncture and Moxibustion (1999), Foreign Languages Press, Beijing 590 pp.
8. Coelho A., Fioramonti J., and Bueno L. Brain interleukin-1β and tumor necrosis factor-alpha are involved in lipopolysaccharide-induced delayed rectal allodynia in awake rats. Brain Res. Bull. 52 (2000) 223-228
9. Docagne F., Campbell S.J., Bristow A.F., Poole S., Vigues S., Guaza C., Perry V.H., and Anthony D.C. Differential regulation of type I and type II interleukin-1 receptors in focal brain inflammation. Eur. J. Neurosci. 21 (2005) 1205-1214
10. Falchi M., Ferrara F., Gharib C., and Dib B. Hyperalgesic effect of intrathecally administered interleukin-1 in rats. Drugs Exp. Clin. Res. 27 (2001) 97-101
11. Fang J.Q., Aoki E., Yu Y., Sohma T., Kasahara T., and Hisamitsu T. Inhibitory effect of electroacupuncture on murine collagen arthritis and its possible mechanisms. In Vivo 13 (1999) 311-318
12. Gayatri S., Mark C.F., and Carlos R.P. Interleukin-1 receptor type I mediates anorexia but not adipsia induced by centrally administered IL-1β. Physiol. Behav. 62 (1997) 1179-1183
13. Hargreaves K., Dubner R., Brown F., Flores C., and Joris J. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32 (1988) 77-88
14. Hart R.P., Liu C., Shadiack A.M., McCormack R.J., and Jonakait G.M. An mRNA homologous to interleukin-1 receptor type I is expressed in cultured rat sympathetic ganglia. J. Neuroimmunol. 44 (1993) 49-56
15. Honore P., Wade C.L., Zhong C., Harris R.R., Wu C., Ghayur T., Iwakura Y., Decker M.W., Faltynek C., Sullivan J., and Jarvis M.F. Interleukin-1alphabeta gene-deficient mice show reduced nociceptive sensitivity in models of inflammatory and neuropathic pain but not post-operative pain. Behav. Brain Res. 167 (2006) 355-364
16. Ji G.C., Zhang Y.Q., Ma F., and Wu G.C. Increase of nociceptive threshold induced by intrathecal injection of interleukin-1beta in normal and carrageenan inflammatory rat. Cytokine 19 (2002) 31-36
17. Lao L.X., Zhang R.X., Zhang G., Wang X., Berman B.M., and Ren K. A parametric study of electroacupuncture on persistent hyperalgesia and Fos protein expression in rats. Brain Res. 1020 (2004) 18-29
18. Lee J.H., Jang K.J., Lee Y.T., Choi Y.H., and Choi B.T. Electroacupuncture inhibits inflammatory edema and hyperalgesia through regulation of cyclooxygenase synthesis in both peripheral and central nociceptive sites. Am. J. Chin. Med. 34 (2006) 981-988
19. Liu X.Y., Zhou H.F., Pan Y.L., Liang X.B., Niu D.B., Xue B., Li F.Q., He Q.H., Wang X.H., and Wang X.M. Electro-acupuncture stimulation protects dopaminergic neurons from inflammation-mediated damage in medial forebrain bundle-transected rats. Exp. Neurol. 189 (2004) 189-196
20. Maier S.F., Wiertelak E.P., Martin D., and Watkins L.R. Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin. Brain Res. 623 (1993) 321-324
21. Mi W.L., Mao-Ying Q.L., Liu Q., Wang X.W., Wang Y.Q., and Wu G.C. Synergistic anti-hyperalgesia of electroacupuncture and low dose of celecoxib in monoarthritic rats: involvement of the cyclooxygenase activity in the spinal cord. Brain Res. Bull. 77 (2008) 98-104
22. O'Connor J., Bensky D., and Acupuncture:. A Comprehensive Text (1981), Eastland Press, Chicago 741 pp.
23. Oka T., Aou S., and Hori T. Intracerebroventricular injection of interleukin-1 beta induces hyperalgesia in rats. Brain Res. 624 (1993) 61-68
24. Oka T., Aou S., and Hori T. Intracerebroventricular injection of interleukin-1β enhances nociceptive neuronal responses of the trigeminal nucleus caudalis in rats. Brain Res. 656 (1994) 236-244
25. Pertovaara A., Hamalainen M.M., Kauppila T., and Panula P. Carrageenan-induced changes in spinal nociception and its modulation by the brain stem. Neuroreport 9 (1998) 351-355
26. Pinteaux E., Parker L.C., Rothwell N.J., and Luheshi G.N. Expression of interleukin-1 receptors and their role in interleukin-1 actions in murine microglial cells. J. Neurochem. 83 (2002) 754-763
27. Rady J.J., and Fujimoto J.M. Confluence of antianalgesic action of diverse agents through brain interleukin-1β in mice. J. Pharmacol. Exp. Ther. 299 (2001) 659-665
28. Samad T.A., Moore K.A., Sapirstein A., Billet S., Allchorne A., Poole S., Bonventre J.V., and Woolf C.J. Interleukin-1beta-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410 (2001) 471-475
29. Sekido R., Ishimaru K., and Sakita M. Corticotropin-releasing factor and interleukin-1beta are involved in the electroacupuncture-induced analgesic effect on inflammatory pain elicited by carrageenan. Am. J. Chin. Med. 32 (2004) 269-279
30. Seo Y.J., Kwon M.S., Shim E.J., Park S.H., Choi O.S., and Suh H.W. Changes in pain behavior induced by formalin, substance P, glutamate and pro-inflammatory cytokines in immobilization-induced stress mouse model. Brain Res. Bull. 71 (2006) 279-286
31. Sims J.E., Gayle M.A., Slack J.L., Alderson M.R., Bird T.A., Giri J.G., Colotta F., Re F., Mantovani A., Shanebeck K., Grabstein K.H., and Dower S.K. Interleukin 1 signaling occurs exclusively via the type I receptor. Proc. Natl. Acad. Sci. U.S.A. 90 (1993) 6155-6159
32. Son Y.S., Park H.J., Kwon O.B., Jung S.C., Shin H.C., and Lim S. Antipyretic effects of acupuncture on the lipopolysaccharide-induced fever and expression of interleukin-6 and interleukin-1 beta mRNAs in the hypothalamus of rats. Neurosci. Lett. 319 (2002) 45-48
33. Souter A.J., Garry M.G., and Tanelian D.L. Spinal interleukin-1beta reduces inflammatory pain. Pain 86 (2000) 63-68
34. Storkson R.V., Kjorsvik A., Tjolsen A., and Hole K. Lumbar catheterization of the spinal subarachnoid space in the rat. J. Neurosci. Methods 65 (1996) 167-172
35. Sung C.S., Wen Z.H., Chang W.K., Ho S.T., Tsai S.K., Chang Y.C., and Wong C.S. Intrathecal interleukin-1beta administration induces thermal hyperalgesia by activating inducible nitric oxide synthase expression in the rat spinal cord. Brain Res. 1015 (2004) 145-153
36. Tadano T., Namioka M., Nakagawasai O., Tan-No K., Matsushima K., Endo Y., and Kisara K. Induction of nociceptive responses by intrathecal injection of interleukin-1 in mice. Life Sci. 65 (1999) 255-261
37. Winter C.A., Risley E.A., and Nuss G.W. Carrageenin-induced edema in hind paw of the rat as an assay for antiiflammatory drugs. Proc. Soc. Exp. Biol. Med. 111 (1962) 544-547
38. Zelenka M., Schafers M., and Sommer C. Intraneural injection of interleukin-1beta and tumor necrosis factor-alpha into rat sciatic nerve at physiological doses induces signs of neuropathic pain. Pain 116 (2005) 257-263
39. Zhang Y.Q., Ji G.C., Wu G.C., and Zhao Z.Q. Excitatory amino acid receptor antagonists and electroacupuncture synergetically inhibit carrageenan-induced behavioral hyperalgesia and spinal fos expression in rats. Pain 99 (2002) 525-535
40. Zhang A., Xu C., Liang S., Gao Y., Li G., Wei J., Wan F., Liu S., and Lin J. Role of sodium ferulate in the nociceptive sensory facilitation of neuropathic pain injury mediated by P2X(3) receptor. Neurochem. Int. 30 (2008) (Epub ahead of print)
41. Zimmermann M. Ethical guidelines for investigation of experimental pain in conscious animals. Pain 16 (1983) 109-110